Align Technology Opens 2026 Annual Research Award Program to Support Innovation in Orthodontics and Dentistry TEMPE, Ariz., [Date] – Align Technology, Inc. (NASDAQ: ALGN), a global leader in medical devices that designs, manufactures, and sells the Invisalign® System of clear…
Transcat Reports Record Fiscal Q2 2026 Performance Fueled by Double-Digit Growth Transcat delivered another strong quarter, achieving double-digit service revenue growth and continued strength in our rentals channel,” said Lee D. Rudow, President and CEO. “Distribution revenue rose 24% year…
Inducement grants include stock options to purchase 90,750 common shares, awarded to three newly hired non-executive employees Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health…
Northwell Health Honors Recipients of Nine Endowed Chairs and Professorships, Advancing Academic Medicine and Patient Care Northwell Health announced the appointment of nine distinguished clinicians, researchers and educators to endowed chairs and professorships, including several inaugural positions spanning biomedical sciences,…
MaaT Pharma’s Pivotal Phase 3 ARES Trial Results for Xervyteg® (MaaT013) in Steroid- and Ruxolitinib-Refractory GI-aGvHD Selected for Oral Presentation at ASH 2025 MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem…
KCAS Bio Expands Board of Directors with Appointment of Industry Leaders Dr. Paul Kirchgraber and Mr. Kurt Doyle KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, today announced the appointment of Dr. Paul…
Phase III ALLEGORY trial achieved its primary and all key secondary endpoints with Gazyva, an anti-CD20 monoclonal antibody engineered to enhance B cell depletion. – Gazyva shows potential to become a transformative new standard of care for up to 3.4…
Samsung Epis Holdings Co., Ltd. today announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Samsung Biologics (KRX: 207940.KS). The company is set to be listed on the Korea Exchange (KRX)…
HRC Fertility, one of the largest and most respected providers of advanced fertility care in the United States, has announced its sponsorship of two major events dedicated to advancing reproductive and healthcare innovation. The organization is proudly sponsoring the 2025…
Enigma Biomedical USA Announces FDA Acceptance of New Drug Application for Tau PET Radiodiagnostic MK-6240 in Alzheimer’s Diseas Biomedical USA (EB USA) today announced that the U.S. Food and Drug Administration (FDA) has formally accepted the New Drug Application (NDA)…